Galecto (NASDAQ: GLTO)
|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
You can purchase shares of Galecto (NASDAQ: GLTO) through any online brokerage.
There are no as such competitors for Galecto.
The latest price target for Galecto (NASDAQ: GLTO) was reported by Credit Suisse on Friday, August 6, 2021. The analyst firm set a price target for 7.00 expecting GLTO to rise to within 12 months (a possible 400.00% upside). 1 analyst firms have reported ratings in the last year.
The stock price for Galecto (NASDAQ: GLTO) is $1.4 last updated May 17, 2022, 7:59 PM UTC.
There are no upcoming dividends for Galecto.
Galecto’s Q2 earnings are confirmed for Thursday, August 4, 2022.
There is no upcoming split for Galecto.
Galecto is in the Healthcare sector and Biotechnology industry. They are listed on the NASDAQ.